Anzeige
Mehr »
Mittwoch, 29.10.2025 - Börsentäglich über 12.000 News
Die 80-Milliarden-Dollar-Nuklear-Renaissance: Warum Uran der heißeste Sektor der Welt ist
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

NASDAQ Biotech 

WKN:  ISIN:  
Markt oder Branche auswählen:

Aktuelle News zu Aktien im NASDAQ Biotech

  • 24 h
  • 7 Tage
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:  Alle DE EN
LeserMedien
13:15BridgeBio Pharma Lines Up Another 'Domino' As It Nears A Record High2
13:10Should You Buy, Hold, or Sell GILD Stock Ahead of Q3 Earnings?3
13:00RECURSION PHARMACEUTICALS, INC. - 8-K, Current Report2
12:46Goldman Sachs meldet Long- und Short-Position in Avadel Pharmaceuticals4
12:42Anavex Life Sciences' Alzheimer's Drug Candidate Shows Continued Long-Term Benefit Versus Control Group6
12:36Anavex Life Sciences Corp.: Anavex Life Sciences Announces Continued Long-Term Benefit from Oral Blarcamesine Compared to Decline Observed in the Alzheimer's Disease Neuroimaging Initiative (ADNI) Control Group84ADAS-Cog13 difference -12.78 (P 77.4 Weeks (17.8 Months) 'time saved' with oral blarcamesine compared to ADNI Restoring impaired Autophagy - preceding amyloid-beta and tau NEW YORK, Oct. 29, 2025...
► Artikel lesen
12:30BridgeBio Pharma stock climbs after positive Phase 3 results for ADH1 drug1
12:22Positive Phase-3-Studiendaten beflügeln Aktie von BridgeBio Pharma9
12:12Ionis Pharmaceuticals GAAP EPS of -$0.80 beats by $0.43, revenue of $157M beats by $26.49M4
12:06IONIS PHARMACEUTICALS INC - 8-K, Current Report1
12:06EyePoint Pharmaceuticals, Inc.: EyePoint to Report Third Quarter 2025 Financial Results on November 5, 20252
12:06AMARIN CORP PLC - 10-Q, Quarterly Report3
11:46United Therapeutics verfehlt Q3-Erwartungen trotz Rekordumsatz4
11:46United Therapeutics: EPS verfehlt Schätzungen um 0,16 $ - Umsatz schlechter als erwartet1
11:36United Therapeutics GAAP EPS of $7.16 beats by $0.20, revenue of $799.5M misses by $13.37M1
11:36Compass Pathfinder Limited: Compass Pathways Appoints Dr. Jeffrey Jonas to Board of Directors134Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the appointment of Dr. Jeffrey...
► Artikel lesen
11:36Kyverna Therapeutics, Inc.: Kyverna Therapeutics Announces Positive Interim Phase 2 Data from KYSA-6 Study of KYV-101 in Generalized Myasthenia Gravis at AANEM 202531Compelling results set new clinical standard in generalized myasthenia gravis (gMG), increasing confidence in the Company's registrational KYSA-6 Phase 3 MG trial 100% of patients achieved clinically...
► Artikel lesen
11:34UNITED THERAPEUTICS Corp - 8-K, Current Report-
11:34COMPASS Pathways plc - 8-K, Current Report-
11:32UNITED THERAPEUTICS Corp - 10-Q, Quarterly Report-
Weiter >>